Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Rectal Neoplasms 23Colonic Neoplasms 16Colorectal Neoplasms 14Breast Neoplasms 11Stomach Neoplasms 5Pancreatic Neoplasms 5Bile Duct Neoplasms 5Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Liver Neoplasms 3Gallbladder Neoplasms 3Breast Neoplasms, Male 3Neoplasm Metastasis 2Inflammatory Breast Neoplasms 2Head and Neck Neoplasms 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Waldenstrom Macroglobulinemia 1Turcot syndrome 1Somatostatinoma 1Sezary Syndrome 1Salivary Gland Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Pancreatic Intraductal Neoplasms 1Ovarian Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Cisplatin 5Paclitaxel 4Fluorouracil 3sodium thiosulfate 2Cytoreduction Surgical Procedures 2veliparib 1vandetanib 1nilotinib 1birinapant 1Surgical Procedures, Operative 1Semaxinib 1Radiotherapy 1Radiation 1Oxaliplatin 1Mitomycin 1Laparoscopy 1Electrocardiography 1Doxorubicin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Peritoneal Neoplasms × Capecitabine × Clear all
NCT04034251 2026-05-05

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
12 enrolled 18 charts
GastrointestinalGynecologic

Adenocarcinoma, Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡